| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Centre for Research in Women's Health, University of Toronto, Toronto, Ontario, Canada; 2 Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; and 3 Departments of Medicine and Oncology, Cancer Prevention Research Unit, Lady Davis Institute of the Jewish General Hospital and McGill University Montreal, Montreal, Quebec, Canada
Requests for reprints: Steven A. Narod, Centre for Research in Women's Health, University of Toronto, 790 Bay Street, Toronto, Ontario, M5G 1N8 Canada. Phone: (416) 351-3765; Fax: (416) 351-3767. E-mail: steven.narod{at}swchsc.on.ca
Background: Mammographic breast density is a significant risk factor for breast cancer. Women with dense tissue accounting for more than 60–75% of the area of the breast have a 4- to 6-fold increase in their risk of breast cancer, compared to women with little or no breast density. A high circulating level of insulin-like growth factor-I (IGF-I) and low IGF binding protein 3 (IGFBP-3) level have been associated with increased breast density in premenopausal women. Genetic polymorphisms in the IGF1 and IGFBP3 genes may influence breast and serum levels of these growth factors. The aims of this study were to determine whether polymorphic variations in the IGF1 and IGFBP3 genes are associated with breast density, and serum IGF-I and IGFBP-3 levels, and whether serum IGF-I and IGFBP-3 levels are associated with mammographic density. Methods: A total of 441 white women, recruited from Women's College Hospital (Toronto, Ontario), enrolled in this study. Each woman completed a questionnaire, detailing information on age, menstrual history, hormone use, diet, and medical and mammography history. Blood samples were taken for DNA extraction to genotype the subjects for polymorphic variants in the two candidate genes, and for measurement of circulating levels of IGF-I and IGFBP-3. Mammographic films were retrieved from Women's College Hospital and digitized using a laser film scanner. The digitized images were assessed for breast density using a computer-assisted method. Results: There was a positive association between serum IGFBP-3 levels and the number of A alleles at a previously described polymorphic locus in the promoter region of the IGFBP3 gene among premenopausal women (P = 0.01). There was also a positive trend in the mean percentage of breast density by the number of A alleles of the IGFBP3 gene among premenopausal women (P = 0.0005). Women with two A alleles had a 5-fold increase in the odds of having a percentage of breast density greater or equal to 28%, compared with women with no A allele (P = 0.002). However, there was no association between serum IGF-I and IGFBP-3 levels and breast density among premenopausal women (P > 0.05). Conclusions: This is the first study to report a strong relationship between a polymorphic gene locus (IGFBP3) and mammographic breast density. However, we could not confirm an association between serum IGF-I levels and breast density among premenopausal women, as demonstrated in previous studies.
This article has been cited by other articles:
|
|
 |
|
  L. E. Kelemen, V. S. Pankratz, T. A. Sellers, K. R. Brandt, A. Wang, C. Janney, Z. S. Fredericksen, J. R. Cerhan, and C. M. Vachon Age-specific Trends in Mammographic Density: The Minnesota Breast Cancer Family Study Am. J. Epidemiol., May 1, 2008; 167(9): 1027 - 1036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Diorio, J. Brisson, S. Berube, and M. Pollak Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 880 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Vachon, T. A. Sellers, E. E. Carlson, J. M. Cunningham, C. A. Hilker, R. L. Smalley, D. J. Schaid, L. E. Kelemen, F. J. Couch, and V. S. Pankratz Strong Evidence of a Genetic Determinant for Mammographic Density, a Major Risk Factor for Breast Cancer Cancer Res., September 1, 2007; 67(17): 8412 - 8418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Cheng, K. DeLellis Henderson, C. A. Haiman, L. N. Kolonel, B. E. Henderson, M. L. Freedman, and L. Le Marchand Genetic Determinants of Circulating Insulin-Like Growth Factor (IGF)-I, IGF Binding Protein (BP)-1, and IGFBP-3 Levels in a Multiethnic Population J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3660 - 3666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stone, L. C. Gurrin, G. B. Byrnes, C. J. Schroen, S. A. Treloar, E. J.D. Padilla, G. S. Dite, M. C. Southey, V. M. Hayes, and J. L. Hopper Mammographic Density and Candidate Gene Variants: A Twins and Sisters Study Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1479 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Verheus, P. H.M. Peeters, R. Kaaks, P. A.H. van Noord, D. E. Grobbee, and C. H. van Gils Premenopausal Insulin-Like Growth Factor-I Serum Levels and Changes in Breast Density over Menopause Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 451 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Bremnes, G. Ursin, N. Bjurstam, S. Rinaldi, R. Kaaks, and I. T. Gram Insulin-like Growth Factor and Mammographic Density in Postmenopausal Norwegian Women Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 57 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chen, R. Freeman, L. F. Voigt, A. Fitzpatrick, S. R. Plymate, and N. S. Weiss Prostate Cancer Risk in Relation to Selected Genetic Polymorphisms in Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-3, and Insulin-like Growth Factor-I Receptor Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2461 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. F. Boyd, L. J. Martin, L. Sun, H. Guo, A. Chiarelli, G. Hislop, M. Yaffe, and S. Minkin Body Size, Mammographic Density, and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2086 - 2092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. dos Santos Silva, N. Johnson, B. De Stavola, G. Torres-Mejia, O. Fletcher, D. S. Allen, N. E. Allen, T. J. Key, I. S. Fentiman, J. M.P. Holly, et al. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J.B. van Duijnhoven, I. D. Bezemer, P. H.M. Peeters, M. Roest, A. G. Uitterlinden, D. E. Grobbee, and C. H. van Gils Polymorphisms in the Estrogen Receptor {alpha} Gene and Mammographic Density Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2655 - 2660. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Diorio, M. Pollak, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, S. Berube, C. Morin, and J. Brisson Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1065 - 1073. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
